Clinical Trial Update: NWRD09 for HPV-16 Related Cervical HSIL [Phase 1]

View source ↗

Summary

NWRD09 is in Phase 1 clinical testing for HPV-16–related cervical HSIL and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• NWRD09

Snippet

Sponsor: Newish Biotech (Wuxi) Co., Ltd. | Conditions: High-grade Squamous Intraepithelial Lesion (HSIL) | Phase 1 | Status: RECRUITING